Pharmacy Practice
Affordable Medicines
Biosimilars
Compliance
Compounding
Drug Approvals
Geriatrics
Hospital/Health System
In-Pharmacy Vaccines
Law
Medication Management
News & Trends
OTC
Pharmacist Resources
Specialty Pharmacy
Technology
Disease State
Allergy
Autoimmune
Breast Cancer
Cardiovascular
Cold & Flu
COVID-19
Dermatology
Diabetes
Gastroenterology
Hematology
HIV/AIDS
Infectious Disease
Infusion
Lung Cancer
Mental Health
mRNA Technology
Neurology
Oncology
Ophthalmology
Orthopedics
Pain Management
Pediatrics
Respiratory
Schizophrenia
Urology/Nephrology
Women’s Health
Health Awareness Month
Videos
Patient Teaching Aid
Publications
Featured Issue
Featured Supplements
Conference Coverage
Continuing Education
Subscribe
COVID-19 Resources
mRNA Technology
November 16, 2023
COVID-19 Vaccine Effectiveness in Preventing Post-COVID Conditions
November 16, 2023
Important Information Issued About COVID-19 Vaccine Dosage
November 16, 2023
Combination Vaccine Against Influenza, COVID-19 Now in Phase III Trial
October 10, 2023
Moderna Announces Positive Clinical Results, Expansion of mRNA Technology
October 10, 2023
Effectiveness of mRNA COVID-19 Vaccines in Immunocompromised Individuals
October 10, 2023
FDA Approves Moderna’s Updated COVID-19 Vaccine
September 13, 2023
Moderna’s Updated COVID-19 Vaccine Immune Results Against BA.2.86
September 13, 2023
Urticaria Exacerbations After COVID-19 Vaccination?
September 13, 2023
Immune Responses to mRNA COVID-19 Vaccines During Pregnancy
August 15, 2023
Exploring mRNA Technology Use in Oncology Therapeutics
August 15, 2023
Safety, Efficacy of Moderna Vaccine in Older Patients
August 15, 2023
Phase III Melanoma Adjuvant Treatment Study Launched
July 11, 2023
Global Regulatory Submissions for Moderna’s RSV Vaccine Announced
Load More
X
November 2023
In This Issue
Digital Magazine
Archives
Subscription
×
Full Image